# PD-1 Antibody Combined With COX Inhibitor in MSI-H/dMMR or High TMB Colorectal Cancer

> **NCT03638297** · PHASE2 · UNKNOWN · sponsor: **Sun Yat-sen University** · enrollment: 29 (estimated)

## Conditions studied

- Colorectal Cancer

## Interventions

- **DRUG:** PD-1 antibody + cox inhibitor

## Key facts

- **NCT ID:** NCT03638297
- **Lead sponsor:** Sun Yat-sen University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-08-23
- **Primary completion:** 2022-08-20
- **Final completion:** 2025-08-31
- **Target enrollment:** 29 (ESTIMATED)
- **Last updated:** 2023-10-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03638297

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03638297, "PD-1 Antibody Combined With COX Inhibitor in MSI-H/dMMR or High TMB Colorectal Cancer". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT03638297. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*